# FDA Inspection 662226 - Craig L. Slingluff, Jr. MD - May 18, 2010

Source: https://www.keypedia.com/records/fda_inspections/craig-l-slingluff-jr-md/8f458c1b-8a75-470e-8c87-ee93a6110be4
Source feed: FDA_Inspections

> FDA Inspection 662226 for Craig L. Slingluff, Jr. MD on May 18, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 662226
- Company Name: Craig L. Slingluff, Jr. MD
- Inspection Date: 2010-05-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 662226 - 2010-05-18](https://www.keypedia.com/records/fda_inspections/craig-l-slingluff-jr-md/8f21357b-da80-4957-89bf-861ccf661df0)

Company: https://www.keypedia.com/companies/craig-l-slingluff-jr-md/3dd89560-4209-477a-b7a7-7bda70801935

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c